AI assistant
Sending…
Pluri Inc. — Regulatory Filings 2013
Sep 11, 2013
6990_rns_2013-09-11_6b79999c-f870-42be-af02-9a0eaaa365d0.htm
Regulatory Filings
Open in viewerOpens in your device viewer
_________ false
C003�������� ��������� ����2PublicPLURISTEM THERAPEUTICS INC8544Corporation no: C12337-2001Stock Exchange/Market: NASDAQ2753381Matam Park 20 , Haifa 31905 , ISRAEL ,Tel: 074-7107171 , Fax: 074-7107172E.mail address: [email protected] via MAGNA: 11/09/2013 Time of broadcast: 09:43 09:41:50
| Company site: | www.pluristem.com |
Reference: 2013-02-142464
| Israel Securities Authority | Tel Aviv Stock Exchange | |||||
| www.isa.gov.il | www.tase.co.il |
Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.
| Attached hereto is a report on | Granted Key U.S. Patent |
Patent_PAD_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): |
| Previous names of reporting entity: |
| Date of revision of form structure: 04/08/2013 |
| - - - |
| Name of the Signatory: : Aberman Zalman , Position of Signatory in the reporting corporation: Chairman Of The Board & CEO , Name of Employer Company: . |
| Matam Park Telephone: 074-7107171 , Facsimile: 074-7107172 , E-mail: [email protected] 2 |
More from Pluri Inc.
Report Publication Announcement
2026
May 14
Interim / Quarterly Report
2026
May 14
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Apr 23
Report Publication Announcement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Capital/Financing Update
2026
Mar 27